MEP of the week

Lobby organisation

Johnson & Johnson

Business / industry · Health & pharma · HQ: United States · Transparency Register entry

As of 14 September 2026, Johnson & Johnson appears in 72 declared MEP meetings (50 different MEPs), most often with European People's Party.

72
declared meetings
with current MEPs
50
MEPs met
€900,000/yr
declared lobbying spend
self-reported to the register
6.2
lobbyists
full time equivalent

In their own words

“At Johnson & Johnson, we believe good health is the foundation of vibrant lives, thriving communities and forward progress. That’s why for more than 130 years, we have aimed to keep people well at every age and every stage of life. Today, as the world’s largest and most broadly-based health care company, we are committed to using our reach and…”

Stated goals from the organisation's own Transparency Register filing.

Who they meet, and when

Which groups they meet

Share of this organisation's 72 declared meetings, by the meeting MEP's political group.

European People's Party3650%
Socialists & Democrats1926%
Renew Europe710%
Patriots for Europe68%
European Conservatives & Reformists46%

Meetings by year

Declared meetings per calendar year, 2019–2026. Bar length is relative to its busiest year (29 in 2025).

2019
3
2020
0
2021
0
2022
4
2023
9
2024
8
2025
29
2026
19

Group is each MEP's current political group, not necessarily the one they sat with at the time. Shares are rounded to whole percent.

The MEPs they meet most

Tomislav Sokol
5 meetings · EPP
Nicolás González Casares
4 meetings · S&D
Tiemo Wölken
3 meetings · S&D
Vytenis Povilas Andriukaitis
2 meetings · S&D
Andreas Glück
2 meetings · Renew

The 15 most recent declared meetings

DateMEPSubject
11 Sep 2026Karin KarlsbroBattery labeling
30 Jun 2026Carlo CiccioliBiotech Act
23 Jun 2026Lukas MandlBiotech Act I
9 Jun 2026Kristoffer StormEU Biotech Act
1 Jun 2026András GyürkEU Biotech Act
1 Jun 2026Viktória FerencIntroduction, exchange of views on Biotech Act
26 May 2026Tiemo WölkenBiotech Act
11 May 2026Margarita de la Pisa CarriónSANT COMMITTEE ONGOING WORK
29 Apr 2026Nicolás González CasaresPharmaceutical Policy EU-US Trade
28 Apr 2026Ingeborg ter LaakBiotech Act
24 Apr 2026Christian EhlerFP10
15 Apr 2026Andreas GlückMDR Revision
15 Apr 2026Laurent CastilloDispositifs médicaux
8 Apr 2026Tomislav SokolHealth Policy
1 Apr 2026Ingeborg ter LaakBiotech Act

Meeting an MEP is a normal part of democratic life; the record is shown so anyone can see it.